<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=377593866636424&amp;ev=PageView&amp;noscript=1">


Is Our Obsession With AI in Clinical Trials Here to Stay?

How many times in recent years have you heard the term artificial intelligence, or A.I for short, used in any of the following contexts?

AI is taking over our jobs! AI will strengthen the economy! AI is risky and unsafe! AI will drive huge efficiencies!

While there is considerable enthusiasm behind AI, we’ve only just scratched the surface of AI’s capabilities and benefits – and as we know, excitement can come with apprehension about whether we can avoid AI’s potential challenges and pitfalls.

We are in an era where business analytics and big data are driving more and more business decisions. Life sciences companies who can harness the power of AI and big data combined could gain a critical edge in the R&D race.